The value of RSI of Syneos Health's share price is above 70 as of 5th of January 2025. This usually implies that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are
“We have long appreciated Syneos Health’s leadership position in serving large pharma and biotech customers globally, across both clinical development and commercialization,” said Senior Portfolio Manager, Marc Steinberg, on behalf of Elliott. “Syneos Health is at an important stage...
Syneos Health, the only fully integrated biopharmaceutical solutions organization, reported financial results for the three and twelve months ended December 31, 2020.
stock 2 comments 3 likes contra biotech review 1.96k follower s follow summary syneos health inc. is a 22-year-old global biopharmaceutical solutions organization offering a full suite of clinical and commercial services. syneos's competitive advantages are its unique operating model, exceptional ...
In addition, Syneos Health entered into an agreement with the Selling Stockholders to repurchase an aggregate of 600,000 shares of common stock from such Selling Stockholders in a private transaction, concurrently with the closing of the Offering, at the price at which the shares of comm...
Syneos Health Communications has ranked #2 in healthcare and in top 20 overall on the PRWeek UK Top 150 2020. Media May 12, 2020 Payer Priorities in a Pandemic What are payers focused on during the COVID-19 pandemic? Adrian Garcia and Katherine Seay at Syneos Health share their thoughts ...
With climate change increasingly recognized the greateset threat to human health, biopharma businesses can win market share by pivoting toward prevention and reslience. Blog January 2, 2024 It's January 2nd. Time for external stakeholders to set the stage for continued drug price scrutiny It's ...
Syneos Health, Inc. (SYNH) Q4 2020 Earnings Call Transcript SYNH earnings call for the period ending December 31, 2020. Motley Fool Transcribers | Feb 18, 2021 View More SYNH Earnings Transcripts Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio...
Most of Syneos Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syneos Hea...